High Potency API Market Report

Global and Region High Potency API Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：228
  • REPORT CODE：GMM952520
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of High Potency API market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of High Potency APImarket, defines the market attractiveness level of High Potency API market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of High Potency API industry, describes the types of High Potency API market, the applications of major players and the market size, and deeply analyzes the current situation of the global High Potency API market and the development prospects and opportunities of High Potency API industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global High Potency API market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Novartis International

    • Eli Lilly and Company

    • Sanofi

    • Teva Pharmaceutical

    • Boehringer Ingelheim

    • Johnson & Johnson

    • Pfizer

    • Merck & Co

    • Bristol-Myers Squibb

    • Mylan

    • Bayer

    • AbbVie

    By Type:

    • Synthetic HPAPIs

    • Biotech HPAPIs

    By End-User:

    • Oncology

    • Hormonal Disorders

    • Glaucoma

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 High Potency API Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 High Potency API Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 High Potency API Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 High Potency API Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise High Potency API Market Analysis and Outlook to 2022

    • 7.1 Global High Potency API Consumption (2017-2022)

    • 7.2 United States High Potency API Consumption (2017-2022)

    • 7.3 Europe High Potency API Consumption (2017-2022)

    • 7.4 China High Potency API Consumption (2017-2022)

    • 7.5 Japan High Potency API Consumption (2017-2022)

    • 7.6 India High Potency API Consumption (2017-2022)

    • 7.7 South Korea High Potency API Consumption (2017-2022)

    8 Region and Country-wise High Potency API Market Analysis and Outlook to 2028

    • 8.1 Global High Potency API Consumption Forecast (2022-2028)

    • 8.2 United States High Potency API Consumption Forecast (2022-2028)

    • 8.3 Europe High Potency API Consumption Forecast (2022-2028)

    • 8.4 China High Potency API Consumption Forecast (2022-2028)

    • 8.5 Japan High Potency API Consumption Forecast (2022-2028)

    • 8.6 India High Potency API Consumption Forecast (2022-2028)

    • 8.7 South Korea High Potency API Consumption Forecast (2022-2028)

    9 Global High Potency API Market Outlook by Types and Applications to 2022

    • 9.1 Global High Potency API Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Synthetic HPAPIs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biotech HPAPIs Consumption and Growth Rate (2017-2022)

    • 9.2 Global High Potency API Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hormonal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Glaucoma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global High Potency API Market Outlook by Types and Applications to 2028

    • 10.1 Global High Potency API Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Synthetic HPAPIs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biotech HPAPIs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global High Potency API Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global High Potency API Import and Export Analysis (Top 5 Countries)

    • 11.1 Global High Potency API Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global High Potency API Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 High Potency API Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global High Potency API Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline High Potency API Product and Service

    • 14.2 Novartis International

      • 14.2.1 Novartis International Company Details

      • 14.2.2 Novartis International High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Novartis International High Potency API Product and Service

    • 14.3 Eli Lilly and Company

      • 14.3.1 Eli Lilly and Company Company Details

      • 14.3.2 Eli Lilly and Company High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lilly and Company High Potency API Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi High Potency API Product and Service

    • 14.5 Teva Pharmaceutical

      • 14.5.1 Teva Pharmaceutical Company Details

      • 14.5.2 Teva Pharmaceutical High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceutical High Potency API Product and Service

    • 14.6 Boehringer Ingelheim

      • 14.6.1 Boehringer Ingelheim Company Details

      • 14.6.2 Boehringer Ingelheim High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Boehringer Ingelheim High Potency API Product and Service

    • 14.7 Johnson & Johnson

      • 14.7.1 Johnson & Johnson Company Details

      • 14.7.2 Johnson & Johnson High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Johnson & Johnson High Potency API Product and Service

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Details

      • 14.8.2 Pfizer High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Pfizer High Potency API Product and Service

    • 14.9 Merck & Co

      • 14.9.1 Merck & Co Company Details

      • 14.9.2 Merck & Co High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck & Co High Potency API Product and Service

    • 14.10 Bristol-Myers Squibb

      • 14.10.1 Bristol-Myers Squibb Company Details

      • 14.10.2 Bristol-Myers Squibb High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb High Potency API Product and Service

    • 14.11 Mylan

      • 14.11.1 Mylan Company Details

      • 14.11.2 Mylan High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Mylan High Potency API Product and Service

    • 14.12 Bayer

      • 14.12.1 Bayer Company Details

      • 14.12.2 Bayer High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bayer High Potency API Product and Service

    • 14.13 AbbVie

      • 14.13.1 AbbVie Company Details

      • 14.13.2 AbbVie High Potency API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 AbbVie High Potency API Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of High Potency API

    • Figure High Potency API Picture

    • Table Global High Potency API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global High Potency API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global High Potency API Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global High Potency API Consumption by Country (2017-2022)

    • Figure United States High Potency API Consumption and Growth Rate (2017-2022)

    • Table Europe High Potency API Consumption and Growth Rate (2017-2022)

    • Figure China High Potency API Consumption and Growth Rate (2017-2022)

    • Figure Japan High Potency API Consumption and Growth Rate (2017-2022)

    • Figure India High Potency API Consumption and Growth Rate (2017-2022)

    • Figure South Korea High Potency API Consumption and Growth Rate (2017-2022)

    • Figure Global High Potency API Consumption Forecast by Country (2022-2028)

    • Figure United States High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure China High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure India High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea High Potency API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Synthetic HPAPIs Consumption and Growth Rate (2017-2022)

    • Figure Global Biotech HPAPIs Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Hormonal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Glaucoma Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Synthetic HPAPIs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biotech HPAPIs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormonal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glaucoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global High Potency API Import by Region (Top 5 Countries) (2017-2028)

    • Table Global High Potency API Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline High Potency API Product and Service

    • Table Novartis International (Foundation Year, Company Profile and etc.)

    • Table Novartis International High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International High Potency API Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company High Potency API Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi High Potency API Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical High Potency API Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim High Potency API Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson High Potency API Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer High Potency API Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co High Potency API Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb High Potency API Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan High Potency API Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer High Potency API Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie High Potency API Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie High Potency API Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US